Literature DB >> 28223434

Spatial Analysis of Regional Factors and Lung Cancer Mortality in China, 1973-2013.

Xiaoping Shen1, Limin Wang2, Li Zhu3.   

Abstract

Background: China's lung cancer crude death rate has increased 6.9-fold from 1973 to 2014. During this time, the country experienced extremely rapid economic growth and social change. It is important to understand the effects of risk factors on lung cancer mortality (LCM) for better allocation of limited resources of cancer prevention and control in China.
Methods: Using three nationwide mortality surveys from 1973 to 2005, Global Health Data Exchange data in 2013, three nationwide smoking surveys from 1984 to 2013, four population censuses from 1964 to 2000, and other datasets, we have compiled datasets and developed spatial random effect models to assess the association of various area-level-contributing factors on LCM. Spatial scan statistics are used to detect high-risk clusters of LCM.
Results: LCM is higher in urban and more industrialized areas (RR = 1.17) compared with those in rural areas. The level of industrial development's effect is higher for men, which accounts for about 70% of all LCM. Smoking is positively associated with regional variation of LCM rates, and the effect is higher for women than for men.Conclusions: The geographic pattern of high LCM in China is different from that of Western countries. LCM is positively associated with higher socioeconomic status, with more urbanized areas at a higher level of industrial development.Impact: There is a need to further explore additional risk in the high-risk clusters. The study is about China, but this situation may happen in other countries experiencing rapid industrialization and other developing countries. Cancer Epidemiol Biomarkers Prev; 26(4); 569-77. ©2017 AACRSee all the articles in this CEBP Focus section, "Geospatial Approaches to Cancer Control and Population Sciences." ©2017 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2017        PMID: 28223434     DOI: 10.1158/1055-9965.EPI-16-0922

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  7 in total

Review 1.  Clinical significance of blood-based miRNAs as biomarkers of non-small cell lung cancer.

Authors:  Lin Li; Yu Sun; Min Feng; Liang Wang; Jing Liu
Journal:  Oncol Lett       Date:  2018-04-12       Impact factor: 2.967

2.  Modeling the Spatial Distribution of Cancer and Determining the Associated Risk Factors.

Authors:  Lijalem Melie Tesfaw; Essey Kebede Muluneh
Journal:  Cancer Inform       Date:  2020-07-29

3.  Mycobacterium tuberculosis antigens repress Th1 immune response suppression and promotes lung cancer metastasis through PD-1/PDl-1 signaling pathway.

Authors:  Shuhui Cao; Jingwen Li; Jun Lu; Runbo Zhong; Hua Zhong
Journal:  Cell Death Dis       Date:  2019-01-18       Impact factor: 8.469

4.  The Role of Prostaglandin-Endoperoxide Synthase-2 in Chemoresistance of Non-Small Cell Lung Cancer.

Authors:  Xiao-Mian Lin; Wu Luo; Heng Wang; Rong-Zhen Li; Yi-Shan Huang; Lian-Kuai Chen; Xiao-Ping Wu
Journal:  Front Pharmacol       Date:  2019-08-08       Impact factor: 5.810

5.  Cancer burden of major cancers in China: A need for sustainable actions.

Authors:  Maomao Cao; He Li; Dianqin Sun; Wanqing Chen
Journal:  Cancer Commun (Lond)       Date:  2020-05-02

6.  Clinical characteristics of non-small cell lung cancer patients with EGFR mutations and ALK&ROS1 fusions.

Authors:  Qinghua Liu; Qingyan Huang; Zhikang Yu; Heming Wu
Journal:  Clin Respir J       Date:  2022-01-26       Impact factor: 1.761

7.  Province-specific smoking-attributable cancer mortality in China 2013.

Authors:  Linjie Yu; Junxia Cheng; Xiaoli Cui; Jianbing Wang
Journal:  Tob Induc Dis       Date:  2020-06-01       Impact factor: 2.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.